In this study, effects of hot water extract of Paecilomyces hepiali mycelia on hypertension parameters in spontaneously hypertensive rats (SHR) were investigated. The tested parameters included blood pressure, blood and urine biochemical composition, renin and angiotensin II levels in the blood. Prior to these tests, the extract was examined for toxicity. The fungus was cultivated in a solid medium composed of 40 g brown rice, 0.32 g glucose, 0.65 g sucrose, 2 g peptone and 65 ml corn steep liquor. No abnormality or harmful effects were observed in the toxicity test. Administration of a continuous-dose, once daily, to SHR for 27 weeks (from 13 weeks of age) decreased the systolic blood pressure (SBP) significantly. Levels of blood urea nitrogen, β-lipoprotein lipid peroxides and low density lipoprotein were significantly lower in the treated groups when compared to the control group. Urinary protein was significantly reduced in the middle and high dose groups. In comparison with the control group (0 mg/kg/10ml/day), significantly higher values were obtained for total cholesterol in groups that were given middle (170 mg/kg/10ml/day) and high (250 mg/kg/10ml/day) dosages. In all dosages (low, middle and high) the values for triglyceride were significantly higher than value found in the control group. In terms of angiotensin II levels, the value in the control group was markedly higher than values in the other groups. The results suggest that oral administration of hot water extract of P. hepiali mycelia has ability to control hypertension in rats.
Introduction
A number of fungi have been described as anamorphs of Ophiocordyceps sinensis (former name: Cordyceps sinensis). Since the 1980s 22 species in 13 genera have been attributed to the anamorph of O. sinensis [1] . These include Stachybotrys sp., Paecilomyces sinensis, Scytalidium hepiali, Tolypocladium sinensis, Chrysosporium sinensis, Hirsutella sinensis, Synnematium sinensis, Cephalosporium sp., Paecilomyces hepiali, Mortierella hepiali, and Scytalidium hepiali [2] . These species have been used for mass production of mycelia for making various commercial products labelled as O. sinensis or C. sinensis. Chen et al. [2] describes the labelling of mycelia products from all these isolates as O. sinensis or C. sinensis to be confusing to the consumer because at the moment it is only H. sinensis and not the other isolates which have been confirmed as the correct anamorph of O. sinensis [3] - [5] .
Paecilomyces hepiali has been popularly used as an anamorph of O. sinensis. Most of the reported medicinal benefits of artificially cultivated mycelia of O. sinensis are based on clinical trials which had been done on P. hepiali Chen (strain Cs-4). The aseptically fermented mycelia of P. hepiali Chen (strain Cs-4) underwent extensive human testing and clinical trials during the 1980s and resulted in a popular commercial product in China, which was known as Jin-Shui-Bao capsule [6] . However, current reports are discarding this fungus as a correct anamorph of O. sinensis. As indicated earlier, H. sinensis is currently receiving general acceptance as the right anamorph of this mushroom [3] - [5] .
Spontaneously hypertensive rats (SHR) are the most often used species in hypertension research. SHR is a rat model that reflects a primary human hypertension that is inherited in a Mendelian manner [7] . Antihypertensive actions in SHR have been reported for mushrooms such Pleurotus nebrodensis, Ganoderma lucidum, Lentinula edodes and Mycoleptodonoides aitchisonii [8] [9] . It has been suggested that mushrooms lower blood pressure by improving lipid metabolism and kidney function and hindering angiotensin-converting enzymes [10] . As reported by Miyazawa et al. [8] , the strength of antihypertensive actions varies with species. Midoh et al. [11] established that repeated once-daily doses of Porcini (Boletus aestivalis) mushrooms have a stronger blood pressure-lowering effect than that of Agaricus blazei, Lentinula edodes, Lyophyllum decastes and Pleourotus eryngii in SHR.
In this study, effects of hot water extract of P. hepiali mycelia on hypertension related parameters in spontaneously hypertensive rats (SHR) were investigated. The studied parameters included blood pressure, blood and urine biochemical changes, and renin and angiotensin II levels in the blood. Prior to the aforementioned studies, the hot water extract of the fungus was evaluated for toxicity using ICR rats.
Materials and Methods

Fungal Material
The fungal strain used in this study was acquired from the mushroom culture bank at the Laboratory of Forest Resources Management, Kyushu University. It is assigned to accession number KUMB108 in the culture bank.
Preparation of Mycelial Powder
A solid substrate (40 g brown rice, 0.325 g glucose, 0.65 g sucrose, 2 g peptone and 65 ml corn steep liquor) was used to grow mycelia of P. hepiali. The fully colonised substrate was freeze dried before being ground to powder using a Waring blender. The extraction was done using this powder.
Toxicity Test
Acute (14 days), subchronic (90 days) and chronic (52 weeks) toxicity tests were carried out in order to evaluate toxicity of P. hepiali extract. Five weeks old ICR rats, which were purchased from Charles River Laboratories (Japan) Inc., were used. The animals were tested in accordance with OECD (Organisation for Economic Cooperation and Development) guidelines for the testing of chemical products. The extract was administered orally at dose levels of 0 (control), 500, 1000 and 2000 mg/kg. Treatments were initiated after allowing the animals a week of acclimatization. Twelve animals (six male and six females) were used per dose. Animals on the same dose were housed in the same cage. The housing environment was maintained at 22˚C temperature and 12 hours of light time per day. The animals were provided unrestricted access to feed (MF Oriental Yeast Co.) and tap water. Before commencing treatments, animals were fasted for about 6 hours. At the start of administration of doses, the body weight ranges for male and female animals were 30.3 -34.8 g and 23.4 -26.5 g respectively. During the test period, all animals were observed on daily basis for mortality, appearance and signs of intoxication. At the end of test period blood samples were collected from the animals before sacrificing them in order to examine internal organs. Blood samples were subjected to blood chemistry analyses.
Systolic Blood Pressure and Biochemical Analyses of Blood and Urine
Experimental Animals
Seven week old male spontaneously hypertensive rats (SHR) purchased from Charles River Laboratories Japan, Inc. were used in this study. The animals were kept at 22˚C ± 1˚C temperature, 60% ± 10% humidity, 12 hours light time (from 7:00 am) and 12 hours dark time (from 7:00 pm). The animals were allowed a one week period of acclimatization before applying any experimental treatment. During this period, they were fed on MF Powder (Oriental Yeast Co., Ltd, Tokyo, Japan) and given access to distilled water. MF Powder supplemented with 8% Sodium Chloride was given to the animals from 9 to 13 weeks of age to raise their blood pressure.
Administration of Doses
After 13 weeks of age the animals were divided into four groups based on treatments: Low dose (5 g/60kg/ 600ml/day), medium dose (10 g/60kg/600ml/day), high dose (15 g/60kg/600ml/day) and control (0 g/60kg/ 600ml/day). Each group was composed of five animals (n = 5). These doses were applied to the groups for 27 weeks (13 -40 weeks). The hot water extract, at dose levels mentioned above, were given to the animals, once daily, by oral administration. All the groups had free access to MF Powder and distilled water.
The hot water extract for the low dose was made by adding 5 g of P. hepiali dry powder into 600 ml of distilled water. The resulting solution was then held in a water bath at 80˚C for 1 hour. After cooling, the supernatant was filtered. The filtrate was placed in a flask and brought to 600 ml by adding distilled water. The extracts for medium and high doses were made by adding 10 g and 15 g respectively. The human weight-based doses of 5 g/60kg/600ml/day (low dose), 10 g/60kg/600ml/day (medium dose) and 15 g/60kg/600ml/day (high dose) were converted to rat doses of 80 mg/kg/10ml/day (low dosage), 170 mg/kg/10ml/day (middle dosage) and 250 mg/kg/10ml/day (high dosage) respectively.
Measurement of Blood Pressure
Measurements of systolic blood pressure (SBP) of rats were made using the non-invasive tail-cuff method (BP-98A, Softron) at the end of 27 weeks after commencement of treatments. The SBP for each animal was recorded as an average of three measurements. All measurements were done in a room with constant temperature and humidity between 11:00 am and 4:00 pm.
Blood and Urine Tests
Animals were deeply anaesthetised (Nembutal, 45 mg/kg) after fasting them from the previous day. Blood sample was drawn from the left ventricle of each animal using a 20G blood drawing needle. Blood samples were subjected to biochemical (Automatic Chemical Analyser: Auto Lab, Radio Immuno Assay) and endocrinology tests. The Endocrinology test was conducted by using Radio Immuno Assay (RIA) to measure renin and angiotensin II levels in the blood. Urine samples, which were collected two days before the end of the test, were analysed for urinary protein content.
Data Analysis
All data, apart from that on blood analysis of ICR rats after toxicity test, are presented as mean ± standard error (SE). Data for blood and urine biochemical analyses were subjected to Analysis of Variance (ANOVA) followed by Tukey's test (p < 0.05) using Minitab 17 statistical software (Minitab Inc.). All graphs are presented with standard error bars.
Results and Discussion
Toxicity Test
This test was conducted to find out if hot water extract of P. hepiali has toxic effects in rats. No abnormality or A. Chioza, S. Ohga 439 sing(s) of toxicity was observed in all internal organs which were inspected. These included the liver and kidneys. As shown in Table 1 , blood analyses for all doses at the end of toxicity test did not show any significant deviations from the control group. No abnormalities in behaviour or external appearance were observed in the animals throughout the test period. These results and observations confirm that the hot-water extract of P. hepiali is a nontoxic substance.
Systolic Blood Pressure (SBP)
Three dose levels (Low dosage: 80 mg/kg/10ml/day, Middle dosage: 170 mg/kg/10ml/day and High dosage: 250 mg/kg/10ml/day) plus control (0 mg/kg/10ml/day) were orally administered to Spontaneously Hypertensive Rats (SHR) for 27 weeks from 13 weeks of age. Figure 1 shows systolic blood pressure values of rats at 40 weeks of age in all the four groups. The value in the control group was significantly higher than the other three groups in which the extract had been administered. This shows that the hot water extract of P. hepiali lowered SBP levels in SHR. The blood pressure lowering ability of the fungus increased with increasing dosage. The results of studies with Agaricus blazei dry powder [12] , Lentinula edodes, Lyophyllum decastes and Pleurotus nebrodensis [10] showed that the antihypertensive effects of macrofungi in SHR are dose dependant. The present study has also confirmed the same with P. hepiali. It has been suggested that mushrooms lower blood pressure by improving lipid metabolism and kidney function and hindering angiotensin-converting enzymes [10] . Table 2 shows results of comparative biochemical analyses of blood and urine samples which were drawn from all the four test groups of rats at the age of 40 weeks. As presented in the Table 2 , levels of blood urea nitrogen, β-lipoprotein lipid peroxides and low density lipoprotein were significantly lower in the treated groups as compared to the control group. Urinary protein was significantly reduced only in the middle and high dose groups. In comparison with the control group (0 mg/kg/10ml/day), significantly higher values were obtained for total cholesterol in groups that were given middle (170 mg/kg/10ml/day) and high (250 mg/kg/10ml/day) dosages. In all dosages (low, middle and high) the values for triglyceride were significantly higher than value found in the control group.
Blood and Urine Biochemical Analyses
Urea is produced in the liver of vertebrates and some other animals as a waste product of protein metabolism. As the blood passes through the kidneys, urea is taken out of the body through urine. As indicted by Miyazawa et al. [10] , blood urea nitrogen (BUN) is used as an indicator of kidney function and an increase in urea nitrogen may affect protein metabolism. In this study, BUN levels in all the groups which were given P. hepiali hot water extract were significantly lower than the value in the control group. Midoh et al. [11] found that administration of hot water extract of Boletus aestivalis brought about reductions of BUN and creatinine (Cre) in SHR, which are indictors of renal clearance, suggesting that the mushroom may act to improve the renal function. The lower BUN values in the groups which were given P. hepiali extract in this study may also be suggesting that this fungus has ability to improve the renal function in SHR.
A small quantity of low molecular weight proteins are allowed to filtrate in a normal kidney and most of them are reabsorbed in tubules. The presence of high amounts of proteins in urine could be a sign of an important renal disease [13] . In this study, significantly lower values of urinary protein were obtained in the middle and high dosage groups as compared to the control group. This finding would be suggesting that the hot water extract of P. hepiali has improvement effect on the renal system in SHR. However, it should be noted that this study did not look at the actual mechanism(s) involved in this effect.
A renal system that is not functioning well may result in reduced sodium excretion and thereby bringing about an elevation of blood pressure, while an elevated blood pressure may lead to nephrosclerosis and subsequent impairment of the renal function [14] [15] . Results on blood and urine biochemical analysis, especially with regard to urinary protein and blood urea nitrogen (BUN), in the groups that were given the hot water extract of P. hepiali may be suggesting that this fungus improved the renal system which may have resulted in the reduced blood pressure in SHR. It may also be the other way round; the lower blood pressure values recorded in rats which were given the fungus' extract may have improved the renal system. Further studies need to be done to ascertain that.
In comparison with the control group, the values for total cholesterol and triglyceride (blood lipids) were significantly higher in all groups which had been given the extract ( Table 2 ). However, low density lipoprotein (LDL) levels were significantly lower in the low, middle and high dosage groups as compared to the control group. LDL is known as "bad" cholesterol [16] because high levels of this cholesterol can lead to atherosclerosis and cardiovascular disease [17] . As described by Reddin [18] , hypertension can cause atherosclerosis and atherosclerosis causes high blood pressure. In atherosclerosis condition the heart requires greater pumping to allow blood pass through the arteries which have lost elasticity and that elevates blood pressure. On the other hand, elevated blood pressure can cause damage to the surface cells lining the inside of arteries and this condition is thought to initiate atherosclerosis. In the present study both SBP and LDL were significantly lower in groups which were given the extract as compared to control. There is a possibility that one of these had a lowering effect on the other.
Renin and Angiotensin II Levels
Renin level in the control group was significantly lower than all values in the other groups which were given the hot water extract of P. hepiali (Figure 2(a) ). The value was highest in the middle dosage group followed by the low dosage group. In terms of angiotensin II levels, the value in the control group was markedly higher than values in the other groups (Figure 2(b) ).
Renin, which is secreted by the kidneys when low blood volume is detected, stimulates production of angiotensin I, which is converted into angiotensin II. Among other effects, angiotensin II increases blood pressure. In the present study, the level of angiotensin II in the control group was significantly higher than in the groups that were given the extract. As shown in Figure 1 , the control group also had a significantly higher SBP value than the treated groups. This may be demonstrating the involvement of angiotensin II in raising SBP. As indicated by Midoh et al. [11] , the ingredients in natural mushrooms which are reported as being responsible for lowering blood pressure include peptides. This effect is achieved through inhibition of angiotensin conversion.
Conclusion
This study has confirmed that the hot water extract of P. hepiali mycelia is nontoxic substance. It has also demonstrated possibilities of improvement effect on the renal function in SHR. The high blood pressure-lowering ability has also been shown. However, the study did not look at the actual active compounds in the fungus that would be responsible for these effects. The mechanism of the involved active compound(s) also needs to be investigated in future researches.
